Whitney Ijem

Stock Analyst at Canaccord Genuity

(1.68)
# 1648
Out of 5,441 analysts
121
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
PASG Passage Bio
Maintains: Buy
260 67
5.92 1031.76% 7 Aug 14, 2025
GUTS Fractyl Health
Maintains: Buy
12 6
0.97 518.56% 1 Aug 14, 2025
TSHA Taysha Gene Therapie...
Maintains: Strong Buy
11 14
2.75 409.09% 11 Aug 13, 2025
RARE Ultragenyx Pharmaceu...
Maintains: Buy
136 128
27.39 367.32% 9 Aug 8, 2025
VRTX Vertex Pharmaceutica...
Maintains: Hold
424 411
374.47 9.76% 9 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
8.11 134.28% 1 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
390 415
434.89 -4.57% 9 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 10
2.93 241.3% 9 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
92 105
94.32 11.32% 8 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 13
11.13 16.8% 6 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
74 54
10.75 402.33% 6 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
53 52
41.54 25.18% 3 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 66
11.39 479.46% 6 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 11
8.16 34.8% 6 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 90
4.01 2144.39% 2 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 6
0.68 782.35% 6 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
17.95 735.65% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
56.8 47.89% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
22.47 33.51% 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
120 240
3.73 6334.32% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018